We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA, Drugmakers Find Duplicative Requirements in CMC Biologics Guidance
PhRMA, Drugmakers Find Duplicative Requirements in CMC Biologics Guidance
The FDA should avoid duplicating existing requirements in its updated guidance on chemistry, manufacturing and controls information for biologics, according to PhRMA and several drugmakers in comments to the agency.